But what we’ve discovered, is that there may be critical timepoints at which ganglion cells can survive, and potentially thrive again if the stressors from glaucoma are relieved. Glaucoma has classically been thought of as a one-way street, where retinal ganglion cells slowly die, and patients lose vision. Glaucoma: Can ganglion cells improve in function? And how would we measure it? Flora has a keen interest in advancing clinical tools for ocular diseases, such as glaucoma, to improve patient outcomes. She spent a few years at the Centre for Eye Research Australia, focusing on shortening the timeframe to detect glaucoma progression in the clinic and how we can use the retina as a biomarker for other neurodegenerative diseases. Flora Hui from the Department of Optometry and Vision Sciences Biographies and Presentation Summariesįlora completed her Bachelor of Optometry at the University of Melbourne, and her Masters and PhD studies in the same Department. Guest speakers: Professor Allison McKendrick and Dr.

Seeing Beyond Lecture Series 2020: Optometry toolbox: Future and current assessments of visual function for glaucoma Ayton provided an excellent update on advances in gene therapy and clinical trials for patients with inherited retinal regenerations and glaucoma. Thank you to all who attended (and rural practitioners who joined us online). On Wednesday the 2nd of October 2019, Professor Keith Martin and Dr Lauren Ayton presented at the Department’s Seeing Beyond Lecture Series.

Download beyond 2020 optometry